Malaria in Kenya's western highlands

Emerging Infectious Diseases

Volumn 11, Issue 9, 2005, Pages 1425-1432

  Shanks, G Dennis ^a,e   Hay, Simon I ^b,c   Omumbo, Judy A ^c   Snow, Robert W ^c,d  

^a US Army Medical Research Unit Kenya   (Kenya)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c KENYA MEDICAL RESEARCH INSTITUTE   (Kenya)

^d JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^e NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; CHLOROQUINE;

ANOPHELES; DISEASE CARRIER; DISEASE TRANSMISSION; EPIDEMIC; GAMETOCYTE; HEALTH SERVICE; HUMAN; KENYA; MALARIA; NONHUMAN; PLASMODIUM FALCIPARUM; REVIEW; TREATMENT FAILURE;

EID: 23944445268     PISSN: 10806040     EISSN: None     Source Type: Journal    
DOI: 10.3201/eid1109.041131     Document Type: Review

References (41)

1. Abeku TA, van Oortmarssen GJ, Borsboom G, de Vlas SJ, Habbema JD. Spatial and temporal variations of malaria epidemic risk in Ethiopia: factors involved and implications. Acta Trop. 2003;87:331-40.
2. Lindblade KA, O'Neill DB, Mathanga DP, Katungu J, Wilson ML. Treatment for clinical malaria is sought promptly during an epidemic in a highland region of Uganda. Trop Med Int Health. 2000;5:865-75.
3. Malakooti MA, Biomndo K, Shanks GD. Re-emergence of epidemic malaria in the highlands of western Kenya. Emerging Infect Dis. 1998;4:671-6.
4. Shanks GD, Biomndo K, Guyatt HL, Snow RW. Travel as a risk factor for uncomplicated Plasmodium falciparum malaria in the highlands of western Kenya. Trans R Soc Trop Med Hyg. 2005;99:71-4.
5. Roberts JM. The control of epidemic malaria in the highlands of western Kenya. 3. After the campaign. J Trop Med Hyg. 1964;67:230-7.
6. Rogers DJ, Randolph SE, Snow RW, Hay SI. Satellite imagery in the study and forecast of malaria. Nature. 2002;415:710-5.
7. Shanks GD, Hay SI, Stem DI, Biomndo K, Snow RW. Meteorologic influences on Plasmodium falciparum malaria in the highland tea estates of Kericho, western Kenya. Emerg Infect Dis. 2002;8:1404-8.
8. Hay SI, Cox J, Rogers DJ, Randolph SE, Stem DI, Shanks GD, et al. Climate change and the resurgence of malaria in the east African highlands. Nature. 2002;415:905-9.
9. Hay SI, Simba M, Busolo M, Noor AM, Guyatt HL, Ochola SA, et al. Defining and detecting malaria epidemics in the highlands of western Kenya. Emerg Infect Dis. 2002;8:555-62.
10. Shretta R, Omumbo J, Rapuoda B, Snow RW. Using evidence to change antimalarial drug policy in Kenya. Trop Med Int Health. 2000;5:755-64.
11. Spencer HC, Kaseje DC, Brandling-Bennett AD, Oloo AJ, Churchill FC, Koech DK. Changing response to chloroquine of Plasmodium falciparum in Saradidi, Kenya, from 1981 to 1984. Ann Trop Med Parasitol. 1987;81(Suppl 1):98-104.
12. Masaba SC, Anyona DB, Chepkwoni DK. In vitro response of Plasmodium falciparum to chloroquine in the Nandi district, Kenya. Bull World Health Organ. 1985;63:593-5.
13. Rapuoda BA, Ouma JH, Njagi K, Khan B, Omar S. Status of antimalarial drugs sensitivity in Kenya. Malaria and Infectious Diseases in Africa. 1996;8:25-43.
14. Shanks GD, Biomndo K, Hay SI, Snow RW. Changing patterns of clinical malaria since 1965 in a highland area of Kenya: possible role of drug resistance. Trans R Soc Trop Med Hyg. 2000;94:253-5.
15. Matson AT. The history of malaria in Nandi. East Afr Med J. 1957;34:431-41.
16. Chataway JHH. Report on the malaria epidemic in the Lumbwa Reserve (August, 1928). Kenya and East African Medical Journal. 1929;5:303-9.
17. Strangeways-Dixon D. Paludrine (proguanil) as a malarial prophylactic amongst African labour in Kenya. East Afr Med J. 1950;27:127-30.
18. Garaham PCC. Malaria epidemics at exceptionally high altitudes in Kenya. BMJ. 1945;2:45-7.
19. Marsh K, Forster D, Waruiru C, Mwangi I, Winstanley M, Marsh V, et al. Indicators of life-threatening malaria in African children. N Engl J Med. 1995;332:1399-404.
20. Hay SI, Noor AM, Simba M, Busolo M, Guyatt HL, Ochola SA, et al. Clinical epidemiology of malaria in the highlands of western Kenya. Emerg Infect Dis. 2002;8:543-8.
21. Shanks GD, Biomndo K, Maguire J. Travel as a risk factor for malaria requiring hospitalization on a highland tea plantation in western Kenya. J Travel Med. 2004;11:354-7.
22. Zucker JR, Ruebush TK II, Obonyo C, Otieno J, Campbell CC. The mortality consequences of the continued use of chloroquine in Africa: experience in Siaya, western Kenya. Am J Trop Med Hyg. 2003;68:386-90.
23. Abeku TA, Hay SI, Ochola S, Langi P, Beard B, de Vlas SJ, et al. Malaria epidemic early warning and detection in African highlands. Trends Parasitol. 2004;20:400-5.
24. Hay SI, Were EC, Renshaw M, Noor AM, Ochola SA, Olusanmi I, et al. Forecasting, warning, and detection of malaria epidemics: a case study. Lancet. 2003;361:1705-6.
25. Sutherland CJ, Alloueche A, Curtis J, Drakeley CJ, Ord R, Duraisingh M, et al. Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes. Am J Trop Med Hyg. 2002;67:578-85.
26. Shute PG, Maryon M. The effect of pyrimethamine (daraprim) on the gametocytes and oocytsts of Plasmodium falciparum and Plasmodium vivax. Trans R Soc Trop Med Hyg. 1954;48:50-63.
27. Robert V, Awono-Ambene HP, Le Hesran JY, Trape JF. Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine. Am J Trop Med Hyg. 2000;62:210-6.
28. Hogh B, Gamage-Mendis A, Butcher GA, Thompson R, Begtrup K, Mendis C, et al. The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector. Am J Trop Med Hyg. 1998;58:176-82.
29. Roberts JM. Pyrimethamine (Daraprim) in the control of epidemic malaria. J Trop Med Hyg. 1956;59:201-8.
30. Nosten F, van Vugt M, Price R, Luxemburger C, Thway KL, Brockman A, et al. Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet. 2000;356:297-302.
31. von Seidlein L, Milligan P, Pinder M, Bojang K, Anyalebechi C, Gosling R, et al. Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet. 2000;355:352-7.
32. Hay SI, Myers MF, Burke DS, Vaughn D, Endy T, Ananda N, et al. Etiology of mosquito-borne disease epidemics. Proc Natl Acad Sci U S A. 2000;97:9335-9.
33. Thomas C. Malaria: a changed climate in Africa? Nature. 2004;427:690-1.
34. Small J, Goetz SJ, Hay SI. Climatic suitability for malaria transmission in Africa, 1911-1995. Proc Natl Acad Sci U S A. 2003;100:15341-5.
35. Snow RW, Ikoku A, Omumbo J, Ouma J. The epidemiology, politics and control of malaria epidemics in Kenya: 1900-1998. Nairobi, Kenya: World Health Organization. Report prepared for Roll Back Malaria, Resource Network on Epidemics; July 1999.
36. Greenberg AE. Hospital-based surveillance of malaria-related paediatric morbidity and mortality in Kinshasa, Zaire. Bull World Health Organ. 1989;67:189-96.
37. Bodker R, Kisinza W, Malima R, Hsangeni H, Lindsay SW. Resurgence of malaria in the Usambara mountains, Tanzania, an epidemic of drug-resistant parasites. Global Change and Human Health. 2000;1:134-53.
38. Ndyomugyenyi R, Magnussen P. Malaria morbidity, mortality and pregnancy outcome in areas with different levels of malaria transmission in Uganda: a hospital record-based study. Trans R Soc Trop Med Hyg. 2001;95:463-8.
39. Brooker S, Clarke S, Njagi JK, Polack S, Mugo B, Estambale B, et al. Spatial clustering of malaria and associated risk factors during an epidemic in a highland area of western Kenya. Trop Med Int Health. 2004;9:757-66.
40. East African Network for Monitoring Antimalarial Treatment (EANMAT). The efficacy of antimalarial monotherapies, sulphadoxinepyrimethamine and amodiaquine in east Africa: implications for sub-regional policy. Trop Med Int Health. 2003;8:860-7.
41. Muheki C, McIntyre D, Barnes KI. Artemisinin-based combination therapy reduces expenditure on malaria treatment in KwaZulu Natal, South Africa. Trop Med Int Health. 2004;9:959-66.